References
El Hassani M, Marsot A. External evaluation of population pharmacokinetic models for precision dosing: current state and knowledge gaps. Clin Pharmacokinet. 2023;62:533–40. https://doi.org/10.1007/s40262-023-01233-7.
Chung E, Sen J, Patel P, Seto W. Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review. Clin Pharmacokinet. 2021;60:985–1001.
Aljutayli A, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part I: in adults. Clin Pharmacokinet. 2020;59:671–98.
Aljutayli A, El-Haffaf I, Marsot A, Nekka F. An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients. Clin Pharmacokinet. 2022;61:47–70.
Chen N, Guo J, Xie J, Xu M, Hao X, Ma K, et al. Population pharmacokinetics of polymyxin B: a systematic review. Ann Transl Med. 2022;10:231.
Li ZR, Wang CY, Zhu X, Jiao Z. Population pharmacokinetics of levetiracetam: a systematic review. Clin Pharmacokinet. 2021;60:305–18.
Zamir A, Hussain I, Ur Rehman A, Ashraf W, Imran I, Saeed H, et al. Clinical pharmacokinetics of metoprolol: a systematic review. Clin Pharmacokinet. 2022;61:1095–114.
Qin Y, Zhang LL, Ye YR. Parametric population pharmacokinetics of linezolid: a systematic review. Br J Clin Pharmacol. 2022;88:4043–66.
Muda MR, Harun SN, Syed Sulaiman SA, Sheikh Ghadzi SM. Population pharmacokinetics analyses of rifampicin in adult and children populations: a systematic review. Br J Clin Pharmacol. 2022;88:3132–52.
Kiang TK, Sherwin CM, Spigarelli MG, Ensom MH. Fundamentals of population pharmacokinetic modelling: modelling and software. Clin Pharmacokinet. 2012;51:515–25.
Cheng Y, Wang CY, Li ZR, Pan Y, Liu MB, Jiao Z. Can population pharmacokinetics of antibiotics be extrapolated? Implications of external evaluations. Clin Pharmacokinet. 2021;60:53–68.
Hughes JH, Tong DMH, Faldasz JD, Frymoyer A, Keizer RJ. Evaluation of neonatal and paediatric vancomycin pharmacokinetic models and the impact of maturation and serum creatinine covariates in a large multicentre data set. Clin Pharmacokinet. 2023;62:67–76.
Jiao Z. Basic population pharmacokinetic and pharmacodynamic analysis. 3rd ed. Beijing: Science Press; 2020.
Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, et al. Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement. Clin Pharmacokinet. 2015;54:783–95.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported by Scientific and Technological Project in Henan Province (no. 202102310396 and no. 232102311075).
Conflict of interest
Meng Lv and Shengnan Zhang declare no potential conflicts of interest that might be relevant to this work.
Ethics approval
Not applicable.
Availability of data material and code
Data and code sharing was not applicable to this article as no datasets were generated or analysed during this work.
Author contributions
Meng Lv and Shengnan Zhang contributed to the conception of this letter. The letter was drafted by Meng Lv and Shengnan Zhang, and critically revised by Meng Lv.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Code availability
Not applicable.
Rights and permissions
About this article
Cite this article
Lv, M., Zhang, S. Comment on: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”. Clin Pharmacokinet 62, 1183–1185 (2023). https://doi.org/10.1007/s40262-023-01271-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-023-01271-1